CN Patent

CN116712422A — 治疗特定患者群体的神经变性病症的方法

Assigned to Alzheon Inc · Expires 2023-09-08 · 3y expired

What this patent protects

本申请涉及治疗特定患者群体的神经变性病症的方法。具体地，本文公开了基于APOE4状况和疾病严重性的组合，使用曲米沙特、缬氨酰基‑3‑氨基‑1‑丙烷磺酸或其药学上可接受的盐来治疗、改善和/或预防特定患者群体的阿尔茨海默氏病的方法。

USPTO Abstract

本申请涉及治疗特定患者群体的神经变性病症的方法。具体地，本文公开了基于APOE4状况和疾病严重性的组合，使用曲米沙特、缬氨酰基‑3‑氨基‑1‑丙烷磺酸或其药学上可接受的盐来治疗、改善和/或预防特定患者群体的阿尔茨海默氏病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116712422A
Jurisdiction
CN
Classification
—
Expires
2023-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Alzheon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.